解剖性肝切除在肝内胆管癌治疗中的作用
该回顾性研究纳入98例行根治性切除的肝内胆管癌患者,比较解剖性肝切除与局部切除的疗效。结果显示解剖性肝切除组手术时间延长,但中位生存时间14个月优于局部切除组的11个月;多因素分析提示肿瘤数量和解剖性肝切除是独立预后因素。
要点
- 解剖性肝切除组中位生存14个月,局部切除组11个月,差异有统计学意义。
- 解剖性肝切除手术时间长于局部切除,但术中出血、输血、并发症和死亡率无差异。
- 肿瘤数量和解剖性肝切除是影响总体生存的独立预后因素。
核心结论
- 与局部肝切除相比,解剖性肝切除在不影响手术安全的同时,可改善肝内胆管癌患者的预后。
研究设计与样本
- 回顾性分析两医院2010年至2015年收治的98例行根治性切除的肝内胆管癌患者,男55例、女43例,中位年龄61岁。
- 按是否接受解剖性肝切除分为局部切除组30例和解剖性肝切除组68例。
主要发现
- 解剖性肝切除组手术时间196.4±94.9分钟,长于局部切除组的166.2±65.7分钟,P=0.027。
- 两组术中出血量、术中输血、术后并发症、术后死亡、术后住院天数差异均无统计学意义(P值均>0.05)。
- 解剖性肝切除组中位生存时间14个月,长于局部切除组的11个月,χ2=4.641,P=0.031。
- 单因素分析显示肿瘤分化程度、肿瘤数量、T分期、N分期、是否解剖性肝切除、术后辅助治疗影响总体生存。
- 多因素分析显示肿瘤数量(HR=0.522,95%CI:0.259~0.974,P=0.042)和解剖性肝切除(HR=1.858,95%CI:1.092~3.161,P=0.022)是独立预后因素。
临床怎么用
- 对肝内胆管癌行根治性切除时,可考虑解剖性肝切除以改善长期生存,但需接受更长手术时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To evaluate the role of anatomical hepatectomy in the treatment of intrahepatic cholangiocarcinoma. Methods: The cases of intrahepatic cholangiocarcinoma who received curative surgery in two hospitals from 2010 to 2015 were analyzed retrospectively. Among the 98 patients enrolled in this study, 55 were male and 43 were female. The median age was 61 years. According to receiving anatomical hepatectomy or not, the 98 cases were divided into two groups: non-anatomical hepatectomy(n=30) and anatomical hepatectomy(n=68). The surgical results were compared between the two groups.Survival curves were plotted by the Kaplan-Meier method and compared by the log-rank test. The influence of each prognostic factor identified by univariate analysis was multivariate analysis by Cox's proportional hazard regression. Results: The duration of surgery was significantly prolonged in the anatomical hepatectomy group((196.4±94.9)minutes vs. (166.2±65.7)minutes, P=0.027), while there was no significant difference in terms of other surgical results such as intraoperative blood transfusion, postoperative morbidity and mortality rate. Compared to non-anatomical hepatectomy, anatomical hepatectomy significantly improved long-term survival results(14 months vs. 11 months)(χ2=4.641, P=0.031). Single variable analysis indicated that tumor differentiation, tumor numbers, T stage, N stage, anatomical hepatectomy and adjuvant therapy significantly affected overall survival. Multivariate analysis demonstrated that tumor numbers(HR=0.522, 95% CI: 0.259-0.974, P=0.042) and anatomical hepatectomy(HR=1.858, 95%CI: 1.092-3.161, P=0.022) were two independent prognostic factors for overall survival. Conclusion: Compared to non-anatomical hepatectomy, anatomical hepatectomy performed for intrahepatic cholangiocarcinoma is not only safe but also beneficial for long-term survival. 目的: 探讨解剖性肝切除在肝内胆管癌治疗中的价值。 方法: 回顾性分析上海交通大学医学院附属新华医院和浙江大学医学院附属第二医院2010年1月1日至2015年12月31日收治的98例行根治性切除的肝内胆管癌患者病例资料,其中男性55例(56.1%),女性43例(43.9%),中位年龄61岁。根据是否接受解剖性肝切除分为局部切除组(n=30)和解剖性肝切除组(n=68),比较两组患者之间手术相关因素。采用Kaplan-Meier方法绘制累积生存率曲线并进行Log-rank检验,采用Cox回归进行预后相关因素分析。 结果: 解剖性肝切除组手术时间[(196.4±94.9)min]长于局部切除组[(166.2±65.7)min](Z=-2.217,P=0.027),两组患者术中出血量、术中输血、术后并发症、术后死亡、术后住院天数的差异均无统计学意义(P值均>0.05)。解剖性肝切除组中位生存时间为14个月,长于局部肝切除组的11个月(χ2=4.641,P=0.031)。总体生存时间的单因素分析结果显示,肿瘤分化程度、肿瘤数量、T分期、N分期、是否解剖性肝切除、术后辅助治疗患者的预后因素。进一步多因素分析结果提示,肿瘤数量(HR=0.522,95%CI:0.259~0.974,P=0.042)和解剖性肝切除(HR=1.858,95% CI:1.092~3.161,P=0.022)是影响肝内胆管癌患者独立预后因素。 结论: 与局部肝切除相比,解剖性肝切除在不影响手术安全的同时,可改善肝内胆管癌患者的预后。.
引用
- Wu XS, Chen Y, Jin YP, et al. [The role of anatomical hepatectomy in the treatment of intrahepatic cholangiocarcinoma]. Zhonghua Wai Ke Za Zhi. 2018. PMID: 29562411. doi:10.3760/cma.j.issn.0529-5815.2018.E005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。